Literature DB >> 35234357

Comment on "clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma".

Xiaofan Wang1, Donglai Chen2, Xuejun Xu1, Yongbing Chen1.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35234357      PMCID： PMC9089220          DOI： 10.1002/cam4.4597

Source DB:  PubMed          Journal:  Cancer Med        ISSN： 2045-7634            Impact factor:   4.711


× No keyword cloud information.
  6 in total

1.  Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.

Authors:  Fangfei Qian; Wenjia Yang; Rui Wang; Jianlin Xu; Shuyuan Wang; Yanwei Zhang; Bo Jin; Keke Yu; Baohui Han
Journal:  J Thorac Cardiovasc Surg       Date:  2017-11-07       Impact factor: 5.209

2.  Accuracy of the IASLC/ATS/ERS histological subtyping of stage I lung adenocarcinoma on intraoperative frozen sections.

Authors:  Humberto E Trejo Bittar; Pimpin Incharoen; Andrew D Althouse; Sanja Dacic
Journal:  Mod Pathol       Date:  2015-05-29       Impact factor: 7.842

3.  Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ≤ 3 cm: accuracy and interobserver agreement.

Authors:  Yi-Chen Yeh; Jun-ichi Nitadori; Kyuichi Kadota; Akihiko Yoshizawa; Natasha Rekhtman; Andre L Moreira; Camelia S Sima; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  Histopathology       Date:  2015-02-05       Impact factor: 5.087

4.  Comparison of SEER Treatment Data With Medicare Claims.

Authors:  Anne-Michelle Noone; Jennifer L Lund; Angela Mariotto; Kathleen Cronin; Timothy McNeel; Dennis Deapen; Joan L Warren
Journal:  Med Care       Date:  2016-09       Impact factor: 3.178

5.  Meta-analysis of adjuvant chemotherapy versus surgery alone in T2aN0 stage IB non-small cell lung cancer.

Authors:  Tianxiang Zhang; Qiang Guo; Ye Zhang; Zhidong Liu; Shijie Zhou; Shaofa Xu
Journal:  J Cancer Res Ther       Date:  2018-01       Impact factor: 1.805

6.  Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma.

Authors:  Di Lu; Jianjun Yang; Xiguang Liu; Siyang Feng; Xiaoying Dong; Xiaoshun Shi; Jianxue Zhai; Shijie Mai; Jianjun Jiang; Zhizhi Wang; Hua Wu; Kaican Cai
Journal:  Cancer Med       Date:  2020-03-24       Impact factor: 4.452
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.